Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp.TNXP · Entity 6169 | Director | May 25, 2021 | May 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tonix Pharmaceuticals Holding Corp.
Report date May 25, 2021 · Filed May 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,001 |
Reported balance
After 2021-05-25 transaction · row 1
1 source rowRow 1 · 2021-05-25 · Purchase · Acquired 5,000 · Balance 5,001 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2021 Filed May 26, 2021 13:07 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | PurchaseCommon Stock | 5,000 | $1.12 | $5,600.00 |
DisclosureSEC source: 0001387131-21-006089 · ownership.xml · nonDerivative · entry 1 Goodman Daniel Wintner · CIK 0001775914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,001 Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:43 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005544 · ownership.xml · derivative · entry 1 Goodman Daniel Wintner · CIK 0001775914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 04, 2020 Filed May 6, 2020 22:32 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 75,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001387131-20-004491 · ownership.xml · derivative · entry 1 Goodman Daniel Wintner · CIK 0001775914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-05-04 F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 06, 2019 Filed May 8, 2019 12:05 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 30,000 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-19-003429 · ownership.xml · derivative · entry 1 Goodman Daniel Wintner · CIK 0001775914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-06 F1 · price: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.